Biology Reference
In-Depth Information
155. Hirose Y, Katayama M, Stokoe D, Haas-Kogan DA, Berger MS,
Pieper RO. The p38 mitogen-activated protein kinase pathway
links the DNA mismatch repair system to the G2 checkpoint and
to resistance to chemotherapeutic DNA-methylating agents. Mol
Cell Biol 2003;
23
:8306
175. Wang X. The expanding role of mitochondria in apoptosis. Genes
Dev 2001;
15
:2922
33.
176. Wajant H. The Fas signaling pathway: more than a paradigm.
Science 2002;
296
:1635
e
6.
177. Roos W, Baumgartner M, Kaina B. Apoptosis triggered by DNA
damage O6-methylguanine in human lymphocytes requires
DNA replication and is mediated by p53 and Fas/CD95/Apo-1.
Oncogene 2004;
23
:359
e
15.
156. Hirose Y, Katayama M, Berger MS, Pieper RO. Cooperative
function of Chk1 and p38 pathways in activating G2 arrest
following exposure to temozolomide.
e
J Neurosurg 2004;
100
:
67.
178. Yanamadala S, Ljungman M. Potential role of MLH1 in the
induction of p53 and apoptosis by blocking transcription on
damaged DNA templates. Mol Cancer Res 2003;
1
:747
e
5.
157. Zhu N, Shao Y, Xu L, Yu L, Sun L. Gadd45-alpha and Gadd45-
gamma utilize p38 and JNK signaling pathways to induce cell
cycle G2/M arrest in Hep-G2 hepatoma cells. Mol Biol Rep
2009;
36
:2075
1060
e
54.
179. Jaiswal AS, Multani AS, Pathak S, Narayan S. N-methyl-N'-nitro-
N-nitrosoguanidine-induced senescence-like growth arrest in
colon cancer cells is associated with loss of adenomatous poly-
posis coli protein, microtubule organization, and telomeric DNA.
Mol Cancer 2004;
3
:3.
180. Roos WP, Kaina B. DNA damage-induced cell death by
apoptosis. Trends Mol Med 2006;
12
:440
e
85.
158. Lynch HT. Hereditary breast cancer. Ann Med 1991;
23
:475
e
7.
159. Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1
and BRCA2 mutations in a large United States sample. J Clin
Oncol 2006;
24
:863
e
71.
160. Dombernowsky SL, Weischer M, Freiberg JJ, Bojesen SE, Tyb-
jaerg-Hansen A, Nordestgaard BG. Missense polymorphisms in
BRCA1 and BRCA2 and risk of breast and ovarian cancer. Cancer
Epidemiol Biomarkers Prev 2009;
18
:2339
e
50.
181. Yan T, Schupp JE, Hwang HS, et al. Loss of DNA mismatch repair
imparts defective cdc2 signaling and G(2) arrest responses
without altering survival after ionizing radiation. Cancer Res
2001;
61
:8290
e
42.
161. Li S, Ting NS, Zheng L, et al. Functional link of BRCA1 and ataxia
telangiectasia gene product in DNA damage response. Nature
2000;
406
:210
e
7.
182. Ibrahim N, He L, Leong CO, et al. BRCA1-associated epigenetic
regulation of p73 mediates an effector pathway for chemo-
sensitivity in ovarian carcinoma. Cancer Res 2010;
70
:7155
e
5.
162. Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH, Brody LC.
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase
upon DNA damage. Nat Genet 2002;
30
:285
e
65.
183. Ray RM, Bhattacharya S, Johnson LR. Mdm2 inhibition induces
apoptosis in p53 deficient human colon cancer cells by activating
p73- and E2F1-mediated expression of PUMA and Siva-1.
Apoptosis 2011;
16
:35
e
9.
163. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and
G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol
2001;
21
:3445
e
44.
184. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and
p73alpha and their collaboration to induce apoptosis. Nature
1999;
399
:809
e
50.
164. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct
G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell
Biol 2002;
22
:1049
e
13.
185. Yuan ZM, Shioya H, Ishiko T, et al. p73 is regulated by tyrosine
kinase c-Abl in the apoptotic response to DNA damage. Nature
1999;
399
:814
e
59.
165. Yamane K, Schupp JE, Kinsella TJ. BRCA1 activates a G2-M cell
cycle checkpoint following 6-thioguanine-induced DNA
mismatch damage. Cancer Res 2007;
67
:6286
e
7.
186. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC,
Kaelin Jr WG. Chemosensitivity linked to p73 function. Cancer
Cell 2003;
3
:403
e
92.
166. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC
a super complex of BRCA1-associated proteins involved in the
recognition and repair of aberrant DNA structures. Genes Dev
2000;
14
:927
e
10.
187. Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family
and programmed cell death. Oncogene 2008;
27
:6507
e
39.
167. Brown JM, Wilson G. Apoptosis genes and resistance to cancer
therapy: what does the experimental and clinical data tell us?
Cancer Biol Ther 2003;
2
:477
21.
188. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY.
Interaction of mismatch repair protein PMS2 and the p53-related
transcription factor p73 in apoptosis response to cisplatin. Proc
Natl Acad Sci, USA 2003;
100
:2420
e
e
90.
168. Lee MW, Kim WJ, Beardsley DI, Brown KD. N-methyl-N'-nitro-
N-nitrosoguanidine activates multiple cell death mechanisms in
human fibroblasts. DNA Cell Biol 2007;
26
:683
e
5.
189. Marinovic-Terzic I, Yoshioka-Yamashita A, Shimodaira H, et al.
Apoptotic function of human PMS2 compromised by the non-
synonymous single-nucleotide polymorphic variant R20Q. Proc
Natl Acad Sci, USA 2008;
105
:13993
e
94.
169. Roos WP, Batista LF, Naumann SC, et al. Apoptosis in malignant
glioma cells triggered by the temozolomide-induced DNA lesion
O6-methylguanine. Oncogene 2007;
26
:186
e
8.
190. Sun G, Jin S, Baskaran R. MMR/c-Abl-dependent activation of
ING2/p73alpha signaling regulates the cell death response to
N-methyl-N'-nitro-N-nitrosoguanidine. Exp Cell Res 2009;
315
:
3163
e
97.
170. Roos WP, Christmann M, Fraser ST, Kaina B. Mouse embryonic
stem cells are hypersensitive to apoptosis triggered by the DNA
damage O(6)-methylguanine due to high E2F1 regulated
mismatch repair. Cell Death Differ 2007;
14
:1422
e
75.
191. Nehme A, Baskaran R, Aebi S, et al. Differential induction of c-
Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch
repair-proficient and -deficient cells exposed to cisplatin. Cancer
Res 1997;
57
:3253
e
32.
171. Park C, Choi BT, Cheong J, Moon SK, Kim CH, Lee WH, et al.
Induction of apoptosis and G2/M arrest by N-methyl-N'-nitro-N-
nitrosoguanidine in human prostate carcinoma cells. Mutat Res
2004;
563
:139
e
7.
192. Nehme A, Baskaran R, Nebel S, et al. Induction of JNK and c-Abl
signalling by cisplatin and oxaliplatin in mismatch repair-
proficient and -deficient cells. Br J Cancer 1999;
79
:1104
e
49.
172. Hickman MJ, Samson LD. Apoptotic signaling in response to
a single type of DNA lesion, O(6)-methylguanine. Mol Cell
2004;
14
:105
e
10.
193. Yi W, Lee TH, Tompkins JD, Zhu F, Wu X, Her C. Physical and
functional interaction between hMSH5 and c-Abl. Cancer Res
2006;
66
:151
e
16.
173. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by
inducing
e
nucleotide
binding
to Apaf-1.
J
Biol Chem
8.
194. Wang X, Zeng L, Wang J, et al. A positive role for c-Abl in Atm
and Atr activation in DNA damage response. Cell Death Differ
2011;
18
:5
e
203.
174. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy
receptors. Curr Opin Cell Biol 1999;
11
:255
2000;
275
:31199
e
e
60.
e
15.
